Drug Type Synthetic peptide |
Synonyms Soblidotin (JAN/INN), NSC-654663, TZT-1027 + [1] |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC39H67N5O6 |
InChIKeyDZMVCVHATYROOS-ZBFGKEHZSA-N |
CAS Registry149606-27-9 |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic Soft Tissue Sarcoma | Phase 2 | United States | 01 Apr 2003 | |
| progressive non-small cell lung cancer | Phase 2 | United States | 01 Apr 2003 | |
| Non-Small Cell Lung Cancer | Phase 2 | - | - | |
| Non-Small Cell Lung Cancer | Phase 2 | - | - | |
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | United States | 06 Nov 2003 | |
| Solid tumor | Phase 1 | Japan | - |
Phase 2 | - | xvxssttiup(mobkltnkjs) = cjgqrdccwq viijfnxesq (lcoqtbhmlw ) View more | Negative | 15 Dec 2006 |






